Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shichimotsukokato (SKT) is a traditional Japanese Kampo medicine (TJ-46) composed of seven herbal ingredients: Rehmannia root, Angelica root, Peony root, Cnidium rhizome, Astragalus root, Phellodendron bark, and Uncaria hook. It is primarily indicated for the treatment of hypertension, particularly in patients with associated symptoms such as headache, dizziness, and stiff shoulders. Research indicates that SKT exerts antihypertensive and renoprotective effects, potentially by suppressing systolic blood pressure and preventing the loss of chloride channel 5 (ClC-5) in the renal proximal tubules, which helps reduce urinary albumin excretion. It is widely used in Japan as an ethical pharmaceutical for managing hypertensive conditions and is studied for its potential to prevent the progression of chronic kidney disease (CKD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shichimotsukokato.